ALTACE

SECTION 2: Hazards identification

Appearance: Yellow, orange, red, or blue hard gelatin capsules

Signal word

WARNING

Hazard statements

Suspected of damaging the unborn child.

Additional information

Short Term: Antihypertensive drug: has blood pressure-lowering properties Accidental ingestion may cause effects similar to those seen in clinical use. In humans, the use of drugs in this class (ACE inhibitors) can cause fetal and neonatal toxicity, including low blood pressure and kidney failure, when they are taken during pregnancy. Known Clinical Effects: Effects reported during clinical use include dizziness, headache, lethargy, changes in blood pressure, nausea, and abdominal pain. Additionally red, itchy, flaky skin (dermatitis), swelling of skin, mucosa, and submucosal tissues (angioneurotic edema), cough, increased potassium, may occur. EU Indication of danger: Toxic to Reproduction: Category 3 EU Hazard Symbols: EU Risk Phrases: R63 - Possible risk of harm to the unborn child. Australian Hazard Classification

Hazardous Ingredients

Non-Dangerous Goods (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.